Elkhorn Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-100
| Closed | -$27.3K | – | 50 |
|
|
2025
Q4 | $27.3K | Buy |
+100
| New | +$27.2K | 0.02% | 36 |
|
|
2025
Q1 | – | Sell |
-1,097
| Closed | -$255K | – | 36 |
|
|
2024
Q4 | $255K | Sell |
1,097
-1,503
| -58% | -$346K | 0.17% | 15 |
|
|
2024
Q3 | $574K | Sell |
2,600
-2,600
| -50% | -$538K | 0.37% | 13 |
|
|
2024
Q2 | $1.02M | Buy |
5,200
+700
| +16% | +$145K | 0.7% | 9 |
|
|
2024
Q1 | $969K | Buy |
4,500
+150
| +3% | +$31.5K | 0.7% | 9 |
|
|
2023
Q4 | $916K | Buy |
4,350
+405
| +10% | +$86.4K | 0.63% | 9 |
|
|
2023
Q3 | $790K | Sell |
3,945
-905
| -19% | -$180K | 0.52% | 9 |
|
|
2023
Q2 | $899K | Buy |
4,850
+1,060
| +28% | +$196K | 0.57% | 9 |
|
|
2023
Q1 | $726K | Buy |
3,790
+790
| +26% | +$143K | 0.48% | 10 |
|
|
2022
Q4 | $504K | Buy |
3,000
+1,690
| +129% | +$294K | 0.35% | 12 |
|
|
2022
Q3 | $232K | Buy |
1,310
+1,240
| +1,771% | +$245K | 0.17% | 20 |
|
|
2022
Q2 | $14K | Buy |
+70
| New | +$14.8K | 0.01% | 45 |
|
|
2021
Q4 | – | Sell |
-1,110
| Closed | -$215K | – | 40 |
|
|
2021
Q3 | $215K | Buy |
1,110
+245
| +28% | +$49.6K | 0.13% | 20 |
|
|
2021
Q2 | $184K | Hold |
865
| – | – | 0.11% | 21 |
|
|
2021
Q1 | $177K | Buy |
865
+100
| +13% | +$19.7K | 0.11% | 21 |
|
|
2020
Q4 | $139K | Buy |
+765
| New | +$130K | 0.09% | 23 |
|
|
2016
Q1 | – | Sell |
-9,800
| Closed | -$888K | – | 49 |
|
|
2015
Q4 | $888K | Sell |
9,800
-2,000
| -17% | -$188K | 0.53% | 18 |
|
|
2015
Q3 | $1.09M | Sell |
11,800
-3,900
| -25% | -$371K | 0.68% | 15 |
|
|
2015
Q2 | $1.46M | Hold |
15,700
| – | – | 0.87% | 9 |
|
|
2015
Q1 | $1.49M | Sell |
15,700
-2,100
| -12% | -$195K | 0.85% | 11 |
|
|
2014
Q4 | $1.58M | Sell |
17,800
-3,900
| -18% | -$330K | 0.92% | 9 |
|
|
2014
Q3 | $1.74M | Sell |
21,700
-10,900
| -33% | -$821K | 1.04% | 10 |
|
|
2014
Q2 | $2.31M | Buy |
32,600
+1,025
| +3% | +$72.1K | 1.31% | 8 |
|
|
2014
Q1 | $2.34M | Buy |
31,575
+1,700
| +6% | +$128K | 1.48% | 8 |
|
|
2013
Q4 | $2.34M | Sell |
29,875
-1,900
| -6% | -$149K | 1.52% | 7 |
|
|
2013
Q3 | $2.35M | Sell |
31,775
-2,625
| -8% | -$193K | 1.71% | 7 |
|
|
2013
Q2 | $2.61M | Buy |
+34,400
| New | +$2.26M | 2.02% | 6 |
|
Other funds holding CME
VCM
VPM
Elkhorn Partners's CME Position: Q1 2026 in Review
Elkhorn Partners sold out of CME Group (CME) in Q1 2026, closing a stake of 100 shares — an estimated $27.3K sold.
Elkhorn Partners first reported a position in CME in Q2 2013 and held it in 27 quarters. The position peaked at $2.61M in Q2 2013. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Elkhorn Partners reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
- Elkhorn Partners sold 100 CME Group shares in Q1 2026, an estimated $27.3K.
- Elkhorn Partners first reported a position in CME Group in Q2 2013 and held it in 27 quarters.
- Elkhorn Partners's CME Group position peaked at $2.61M in Q2 2013.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Elkhorn Partners's 13F filing for Q1 2026, filed 14 May 2026.